These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28821206)

  • 1. Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study.
    Cooney T; Lane A; Bartels U; Bouffet E; Goldman S; Leary SES; Foreman NK; Packer RJ; Broniscer A; Minturn JE; Shih CS; Chintagumpala M; Hassall T; Gottardo NG; Dholaria H; Hoffman L; Chaney B; Baugh J; Doughman R; Leach JL; Jones BV; Fouladi M; Warren KE; Monje M
    Neuro Oncol; 2017 Sep; 19(9):1279-1280. PubMed ID: 28821206
    [No Abstract]   [Full Text] [Related]  

  • 2. External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry.
    Veldhuijzen van Zanten SEM; Lane A; Heymans MW; Baugh J; Chaney B; Hoffman LM; Doughman R; Jansen MHA; Sanchez E; Vandertop WP; Kaspers GJL; van Vuurden DG; Fouladi M; Jones BV; Leach J
    J Neurooncol; 2017 Aug; 134(1):231-240. PubMed ID: 28560664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase 1/2 Trial of Reirradiation for Diffuse Intrinsic Pontine Glioma.
    Amsbaugh MJ; Mahajan A; Thall PF; McAleer MF; Paulino AC; Grosshans D; Khatua S; Ketonen L; Fontanilla H; McGovern SL
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):144-148. PubMed ID: 30610915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium.
    Poussaint TY; Vajapeyam S; Ricci KI; Panigrahy A; Kocak M; Kun LE; Boyett JM; Pollack IF; Fouladi M
    Neuro Oncol; 2016 May; 18(5):725-34. PubMed ID: 26487690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.
    Janssens GO; Gandola L; Bolle S; Mandeville H; Ramos-Albiac M; van Beek K; Benghiat H; Hoeben B; Morales La Madrid A; Kortmann RD; Hargrave D; Menten J; Pecori E; Biassoni V; von Bueren AO; van Vuurden DG; Massimino M; Sturm D; Peters M; Kramm CM
    Eur J Cancer; 2017 Mar; 73():38-47. PubMed ID: 28161497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical approach to re-irradiation for recurrent diffuse intrinsic pontine glioma.
    Krishnatry R; Manjali JJ; Chinnaswamy G; Chatterjee A; Goda JS; Janu A; Sahu A; Jalali R; Gupta T
    Jpn J Clin Oncol; 2021 Apr; 51(5):762-768. PubMed ID: 33521824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged survival after treatment of diffuse intrinsic pontine glioma with radiation, temozolamide, and bevacizumab: report of 2 cases.
    Aguilera DG; Mazewski C; Hayes L; Jordan C; Esiashivilli N; Janns A; Macdonald TJ
    J Pediatr Hematol Oncol; 2013 Jan; 35(1):e42-6. PubMed ID: 23249962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse intrinsic pontine glioma biopsy: a single institution experience.
    Wang ZJ; Rao L; Bhambhani K; Miller K; Poulik J; Altinok D; Sood S
    Pediatr Blood Cancer; 2015 Jan; 62(1):163-5. PubMed ID: 25263768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Main editor's comment to the paper: the response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma. Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek.
    Di Rocco C
    Childs Nerv Syst; 2014 Dec; 30(12):2063. PubMed ID: 25096071
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypofractionated Radiotherapy for Children With Diffuse Intrinsic Pontine Gliomas.
    Hankinson TC; Patibandla MR; Green A; Hemenway M; Foreman N; Handler M; Liu AK
    Pediatr Blood Cancer; 2016 Apr; 63(4):716-8. PubMed ID: 26544789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional MRI cannot predict survival in childhood diffuse intrinsic pontine glioma.
    Hargrave D; Chuang N; Bouffet E
    J Neurooncol; 2008 Feb; 86(3):313-9. PubMed ID: 17909941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients?
    Lobon-Iglesias MJ; Giraud G; Castel D; Philippe C; Debily MA; Briandet C; Fouyssac F; de Carli E; Dufour C; Valteau-Couanet D; Sainte-Rose C; Blauwblomme T; Beccaria K; Zerah M; Puget S; Calmon R; Boddaert N; Bolle S; Varlet P; Grill J
    J Neurooncol; 2018 Mar; 137(1):111-118. PubMed ID: 29198053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The addition of high-dose tamoxifen to standard radiotherapy does not improve the survival of patients with diffuse intrinsic pontine glioma.
    Michalski A; Bouffet E; Taylor RE; Hargrave D; Walker D; Picton S; Robinson K; Pizer B; Bujkiewicz S
    J Neurooncol; 2010 Oct; 100(1):81-8. PubMed ID: 20238235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse pontine glioma in Jordan and impact of up-front prognosis disclosure with parents and families.
    Qaddoumi I; Ezam N; Swaidan M; Jaradat I; Mansour A; Abuirmeileh N; Bouffet E; Al-Hussaini M
    J Child Neurol; 2009 Apr; 24(4):460-5. PubMed ID: 19074045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary: The response and survival of children with recurrent diffuse intrisic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma, by Burzynski G, et al.
    Massimino M; Clerici CA
    Childs Nerv Syst; 2014 Dec; 30(12):2065-6. PubMed ID: 25079885
    [No Abstract]   [Full Text] [Related]  

  • 16. T2-weighted images are superior to other MR image types for the determination of diffuse intrinsic pontine glioma intratumoral heterogeneity.
    Harward S; Harrison Farber S; Malinzak M; Becher O; Thompson EM
    Childs Nerv Syst; 2018 Mar; 34(3):449-455. PubMed ID: 29151166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis.
    Janssens GO; Jansen MH; Lauwers SJ; Nowak PJ; Oldenburger FR; Bouffet E; Saran F; Kamphuis-van Ulzen K; van Lindert EJ; Schieving JH; Boterberg T; Kaspers GJ; Span PN; Kaanders JH; Gidding CE; Hargrave D
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):315-20. PubMed ID: 22682807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: experience at a single institution.
    Chiang KL; Chang KP; Lee YY; Huang PI; Hsu TR; Chen YW; Chang FC; Wong TT
    Childs Nerv Syst; 2010 Aug; 26(8):1035-41. PubMed ID: 20217098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary results of immune modulating antibody MDV9300 (pidilizumab) treatment in children with diffuse intrinsic pontine glioma.
    Fried I; Lossos A; Ben Ami T; Dvir R; Toledano H; Ben Arush MW; Postovski S; Abu Kuidar A; Yalon M; Weintraub M; Benifla M
    J Neurooncol; 2018 Jan; 136(1):189-195. PubMed ID: 29143272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation therapy and concurrent topotecan followed by maintenance triple anti-angiogenic therapy with thalidomide, etoposide, and celecoxib for pediatric diffuse intrinsic pontine glioma.
    Porkholm M; Valanne L; Lönnqvist T; Holm S; Lannering B; Riikonen P; Wojcik D; Sehested A; Clausen N; Harila-Saari A; Schomerus E; Thorarinsdottir HK; Lähteenmäki P; Arola M; Thomassen H; Saarinen-Pihkala UM; Kivivuori SM
    Pediatr Blood Cancer; 2014 Sep; 61(9):1603-9. PubMed ID: 24692119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.